ABGII Modular Femoral Stem and Modular Neck 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Stryker Australia Pty Ltd 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2012-07-23
  • 사례 출판 날짜
    2012-07-23
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: stryker australia pty ltd abgii modular femoral stem and modular neck the therapeutic goods administration (tga), australia issued a medical device safety alert concerning abgii modular femoral stem and modular neck manufactured by stryker australia pty ltd. according to the manufacturer, there is potential for fretting and corrosion at the join between the femoral stem and the neck component of the abgii modular system. fretting and corrosion can result in metal debris in and around the hip joint. if this occurs, patients may experience inflammation, adverse local tissue reactions (altrs), hypersensitivity/allergic reactions and osteolysis (bone loss). stryker australia pty ltd has contacted every australian orthopaedic surgeon who has ever implanted the abgii modular hip replacement system. those surgeons have been asked to contact their patients to discuss what clinical action is most appropriate. if the results reveal that adverse local tissue reaction of patients are due to metal wear debris, the surgeon should consider proceeding with a revision of the femoral component to a monolithic stem. the manufacturer also advised patients that if experiencing hip or thigh pain, or are concerned about the hip replacement, they should contact their implanting surgeon to arrange a review appointment. for details, please refer to tga website http://www.Tga.Gov.Au/safety/alerts-device-abgii-120720.Htm. posted on 23 july 2012.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: Stryker Australia Pty Ltd ABGII Modular Femoral Stem and Modular Neck
  • Manufacturer

Manufacturer

  • 제조사 모회사 (2017)
  • Source
    DH